BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,526 | -31.5% | 8,758 | -17.3% | 0.06% | -28.6% |
| Q2 2023 | $482,708 | -35.5% | 10,595 | -42.5% | 0.08% | -38.9% |
| Q1 2023 | $747,966 | -35.4% | 18,441 | -18.8% | 0.13% | -37.0% |
| Q4 2022 | $1,157,324 | -8.5% | 22,706 | -3.3% | 0.20% | -16.3% |
| Q3 2022 | $1,265,000 | -23.2% | 23,491 | -8.4% | 0.24% | -18.4% |
| Q2 2022 | $1,647,000 | -19.3% | 25,641 | -2.5% | 0.29% | -7.0% |
| Q1 2022 | $2,040,000 | -20.3% | 26,306 | -11.7% | 0.32% | -16.7% |
| Q4 2021 | $2,559,000 | +4.4% | 29,806 | -2.2% | 0.38% | -4.5% |
| Q3 2021 | $2,451,000 | -3.7% | 30,471 | -3.6% | 0.40% | -5.0% |
| Q2 2021 | $2,544,000 | -17.1% | 31,606 | -13.1% | 0.42% | -21.2% |
| Q1 2021 | $3,070,000 | +1.5% | 36,391 | -3.5% | 0.53% | -2.8% |
| Q4 2020 | $3,025,000 | -0.3% | 37,700 | -0.0% | 0.54% | -9.6% |
| Q3 2020 | $3,033,000 | -5.0% | 37,710 | +1.7% | 0.60% | -10.0% |
| Q2 2020 | $3,194,000 | +3.8% | 37,090 | -2.1% | 0.67% | -10.9% |
| Q1 2020 | $3,076,000 | -3.2% | 37,890 | -0.3% | 0.75% | +20.5% |
| Q4 2019 | $3,177,000 | -3.6% | 37,985 | +0.8% | 0.62% | -5.9% |
| Q3 2019 | $3,296,000 | +4.4% | 37,685 | -2.3% | 0.66% | -7.3% |
| Q2 2019 | $3,158,000 | +1.8% | 38,555 | +1.0% | 0.71% | +1.0% |
| Q1 2019 | $3,103,000 | +24.4% | 38,165 | +0.7% | 0.71% | +12.0% |
| Q4 2018 | $2,494,000 | -16.7% | 37,885 | -2.4% | 0.63% | -1.4% |
| Q3 2018 | $2,993,000 | +2.5% | 38,825 | -1.9% | 0.64% | -4.2% |
| Q2 2018 | $2,921,000 | +12.4% | 39,565 | -1.0% | 0.67% | +9.5% |
| Q1 2018 | $2,599,000 | -3.0% | 39,955 | -3.6% | 0.61% | +0.8% |
| Q4 2017 | $2,679,000 | +2.8% | 41,450 | -0.2% | 0.60% | -2.7% |
| Q3 2017 | $2,607,000 | +3.8% | 41,548 | +0.2% | 0.62% | +3.8% |
| Q2 2017 | $2,511,000 | +18.2% | 41,478 | +1.3% | 0.60% | +15.4% |
| Q1 2017 | $2,124,000 | +3.2% | 40,953 | -11.8% | 0.52% | +4.0% |
| Q4 2016 | $2,059,000 | -9.4% | 46,448 | -2.8% | 0.50% | -9.9% |
| Q3 2016 | $2,273,000 | +6.3% | 47,763 | +1.1% | 0.55% | -29.7% |
| Q2 2016 | $2,138,000 | +18.8% | 47,263 | +7.9% | 0.79% | +12.7% |
| Q1 2016 | $1,799,000 | +9.5% | 43,793 | +1.7% | 0.70% | +8.5% |
| Q4 2015 | $1,643,000 | +10.1% | 43,068 | -5.2% | 0.64% | +8.2% |
| Q3 2015 | $1,492,000 | -49.3% | 45,413 | +8.0% | 0.60% | -42.3% |
| Q2 2015 | $2,941,000 | -8.5% | 42,053 | -10.3% | 1.03% | -0.8% |
| Q1 2015 | $3,213,000 | -14.0% | 46,893 | -8.0% | 1.04% | -10.4% |
| Q4 2014 | $3,735,000 | -18.7% | 50,963 | -20.4% | 1.16% | -16.6% |
| Q3 2014 | $4,592,000 | -5.4% | 63,988 | -4.7% | 1.39% | +0.2% |
| Q2 2014 | $4,852,000 | -19.8% | 67,118 | -18.3% | 1.39% | +0.9% |
| Q1 2014 | $6,048,000 | +4.8% | 82,198 | -0.9% | 1.38% | -1.3% |
| Q4 2013 | $5,770,000 | +10.9% | 82,963 | +4.7% | 1.40% | -2.1% |
| Q3 2013 | $5,203,000 | -4.8% | 79,218 | +0.4% | 1.42% | -2.3% |
| Q2 2013 | $5,464,000 | – | 78,888 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |